Thu, 07 Aug 2025

Thu, 07 Aug 2025 Eli Lilly's obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop

Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for weight loss and diabetes drugs.

  >>


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025